NASDAQ: SNSE - Sensei Biotherapeutics, Inc.

半年間の収益性: -20.96%
セクタ: Healthcare

プロモーションスケジュール Sensei Biotherapeutics, Inc.

詳細なスケジュール 簡易グラフ
Financial Markets by TradingView

会社について

Sensei Biotherapeutics, Inc., an immuno-oncology company, engages in the discovery and development of therapeutics for cancer patients. Its Tumor Microenvironment Activated Biologics platform is designed to unleash the anti-tumor potential of T cells, as well as human monoclonal antibodies that are selectively active in the tumor microenvironment and target immune checkpoints or other critical immune pathways. The company's pipeline includes SNS-101, SNS-103, and SNS-102, monoclonal antibodies, which are in early development stages for the treatment of solid tumors.

さらに詳しく
It has a collaboration with The University of Washington to conduct preclinical studies for its SNS-101 program. The company was formerly known as Panacea Pharmaceuticals, Inc. Sensei Biotherapeutics, Inc. was incorporated in 1999 and is headquartered in Rockville, Maryland.
比較リストに追加
ウォッチリストに追加
ポートフォリオに追加
価格通知を追加

EBITDA -0.0124
EV/EBITDA -1.28
IPO date 2021-02-04
ISIN US81728A1088
Industry Biotechnology
P/BV 1
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.senseibio.com
Цена ао 1.04
Число акций ао 0.02795 млрд
1日あたりの価格変動: +3.92% (0.4792)
週ごとの価格変動: +10.69% (0.4499)
月ごとの料金変更: -10.35% (0.5555)
3ヶ月間の価格変動: -10.35% (0.5555)
半年間の価格変動: -20.96% (0.6301)
年間の価格変動: -28.03% (0.692)
3年間の価格推移: -91.31% (5.73)
5年間の価格推移: 0% (0.498)
10年間の価格推移: 0% (0.498)
年初からの価格変動: +9.67% (0.4541)
すべてのパラメータ

過小評価

名前 意味 学年
P/S 0 0
P/BV 0.2886 10
P/E 0 0
EV/EBITDA -0.3268 0
合計: 3.75

効率

名前 意味 学年
ROA, % -45.85 0
ROE, % -52.55 0
合計: 0

配当金

名前 意味 学年
Div yield, % 0 0
DSI 0 0
合計: 0

義務

名前 意味 学年
Debt/EBITDA -0.1701 10
合計: 10

成長の衝動

名前 意味 学年
収益性 Revenue, % 0 0
収益性 Ebitda, % 169.24 10
収益性 EPS, % -20.78 0
合計: 5.6
さらに詳しく

機関 音量 共有, %
Newtyn Management, LLC 1572023 6.27
Vanguard Group Inc 573651 2.29
Renaissance Technologies, LLC 143508 0.57
Geode Capital Management, LLC 136318 0.54
Bridgeway Capital Management, Inc. 112900 0.45
Duquesne Family Office LLC 100000 0.4
Bank of America Corporation 90788 0.36
Millennium Management LLC 38295 0.15
Blackrock Inc. 34813 0.14
Northern Trust Corporation 26049 0.1



スーパーバイザー 役職 支払い 生年
Mr. John K. Celebi M.B.A. President, CEO & Director 882.28k 1972 (53 年)
Dr. Edward Van der Horst Ph.D. Chief Scientific Officer 630.81k 1974 (51 年)
Ms. Lora Pike Vice President of Investor Relations & Communications N/A
Mr. Christopher W. Gerry J.D. Senior VP, General Counsel & Secretary N/A
Ms. Stephanie Krebs M.B.A., M.S. Chief Business Officer N/A 1978 (47 年)
Dr. Aaron Weitzman FACP, M.D., Ph.D. Chief Medical Officer N/A
Mr. Josiah Craver Senior VP of Finance, Principal Financial Officer & Principal Accounting Officer

住所: United States, Rockville. MD, 1405 Research Boulevard - Googleマップで開く, Yandexマップを開く
Webサイト: https://www.senseibio.com